Lifeworks Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Lifeworks Advisors, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $59.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$59.8M
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 74,262 | $10.3M |
| JNJJOHNSON & JOHNSON | 36,895 | $9.0M |
| ABBVAbbVie Inc. | 39,697 | $8.6M |
| MRKMerck & Co., Inc. | 67,492 | $8.1M |
| PFEPFIZER INC | 277,542 | $7.8M |
| ABTABBOTT LABORATORIES | 40,458 | $4.2M |
| VTRSViatris Inc | 225,206 | $3.0M |
| LLYELI LILLY & Co | 1,897 | $1.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 3,022 | $1.3M |
| INCYIncyte Corp. | 10,063 | $947K |
| AMGNAMGEN INC | 2,372 | $835K |
| DGXQuest Diagnostics Incorporated | 4,020 | $788K |
| BIIBBIOGEN INC. | 3,465 | $635K |
| ELVElevance Health Inc. | 1,912 | $560K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,017 | $546K |
| PMPhilip Morris International Inc | 3,044 | $503K |
| BMYBRISTOL MYERS SQUIBB CO | 5,039 | $306K |
| DVADaVita Inc. | 1,810 | $278K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,260 | $235K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.